ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

Intensive Chemo Equivalent To Transplant For MCL

December 26, 2008

In Brief: D. Gary Gilliland Named President and Director of Fred Hutchinson Cancer Research Center

November 21, 2014

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

AACR Cancels $7 Million Annual Meeting, Citing Fear of SARS in Toronto

April 4, 2003